Covaxin reached 30 cities in 30 days, says Bharat Biotech's Suchitra Ella

Bharat Biotech Co-Founder and Joint MD Suchitra Ella on Tuesday said that Covaxin has reached thirty cities in thirty days despite some employees being off work due to Covid

Bharat Biotech, Covaxin
Photo: Shutterstock
Press Trust of India New Delhi
1 min read Last Updated : May 25 2021 | 6:23 PM IST

Bharat Biotech Co-Founder and Joint MD Suchitra Ella on Tuesday said that Covaxin has reached thirty cities in thirty days despite some employees being off work due to COVID.

"COVAXIN reaches 30 cities within 30 day. All our employees are committed, working 24x7 thru lockdowns for the country's immunisation - pls send your prayers to their families, some are still quarantined & off work," Ella said in a tweet.

By way of dispatch to private hospitals, the vaccine has reached various cities, including Amritsar, Bangalore, Chennai, Delhi, Ernakulam, Jaipur, Hyderabad, Kanpur, Kolkata, Guwahati, Mysore, Pune, Raipur, Mohali and Vijayawada.

Last week, Bharat Biotech said it plans to produce additional 200 million (20 crore) doses of Covaxin at its subsidiary's facility in Gujarat. This will take the overall production volume of the vaccine to about 1 billion (100 crore) doses per annum.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: May 25 2021 | 6:20 PM IST

Next Story